Qi Ma

10PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 02, 2026
Preoperative ADT combined with docetaxel for conversion therapy in large-volume and unresectable locally advanced or oligometastatic prostate cancer: a multicenter retrospective study (YHCG-001 study).

|Jul 24, 2026
RON receptor tyrosine kinase regulates abiraterone resistance in prostate cancer via the methylation-dependent and independent dual functions of DNMT1.

|Oct 06, 2025
Current status of radionuclide therapies in metastatic castration-resistant prostate cancer.

Xin Fei, Rui-Da Huang, Xuan Zhou

|Apr 15, 2025
Research progress on circular RNA in the regulation of drug resistance in genitourinary cancers.

Peng-Cheng Hu, Jia-Tao Yao, Ke-Jie Wang

|Feb 14, 2025
Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25.

Yongbo Wang, He Wang, Yipeng Xu

|Nov 18, 2024
RON receptor tyrosine kinase as a critical determinant in promoting tumorigenic behaviors of bladder cancer cells through regulating MMP12 and HIF-2α pathways.

Ke-Jie Wang, Sha-Zhou Ye, Xiao-Long Jia

Pageof 2

Frequent Collaborators

2 joint publications

Ke-Jie Wang

2 joint publications

Rui Yu

2 joint publications

Yongbo Wang

2 joint publications

Xin Fei